SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 25.26-0.7%Jan 7 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Lacelle who wrote (3061)5/29/1998 8:32:00 PM
From: coyote   of 9523
 
I believe that it is mostly slime ball reporting from the type of reporter that chased Lady Di to her death , or else self serving shorters trying to push the stock down. For this rediculously low incidence of death for the type of patient profile we have gone way past the point of talking it to death.
Even Israel by stopping or delaying sales is probably doing it for political reasons ,not health reasons. ie since you don't use one of our local drug companies for distribution we will make it a little more difficult for you to get this product going.Most of these so called approval boards delay approval of these new (expensive) drugs
for budgetary reasons and for the pork barrel jobs that the local equivalent of the FDA serves.Any side effect that they are testing for has usually already been documented by the original research.IMHO
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News